中
News

Nanodigmbio@ICG-14

View: 6827 / Time: 2019-10-28


On October 24-27, the 14th International Genomics Conference ICG-14 was successfully concluded in Shenzhen.

This conference continued the theme of “Gene technology for the benefit of mankind”, focusing on the theme of “Second Wave of Sequencing, Technologies and Applications of Biological Intelligence and Big Data”. More than 60 domestic and foreign scientists gave keynote speeches and shared latest discoveries. Nanodigmbio was invited to deliver two keynote speeches, illustrating Nanodigmbio's latest research progress in targeted sequencing and the exceptional performance of the solution on MGI platforms.

On the morning of October 25th, at the main forum of the ICG-14, Dr. Wenli Zheng, CTO of Nanodigmbio, gave a keynote speech titled Continuous Improvement and Optimization on targeted Sequencing for Precision Oncology, which focused on optimized targeted solution for cell-free DNA and microsatellite markers. 



ICG-14-wenli


On the afternoon of October 26, at the 2019 MGI Cooperative Product Launch Conference, Yaxin Xue from Nanodigmbio introduced Nanodimgbio's NGS total solution of targeted sequencing on MGI platforms in the Nano Trans More_Ready-to-Use Target Enrichment Solution on MGI speech. The speech highlighted the excellent performance of low-frequency mutation detection and exome sequencing on the DNBSEQ-G400 platform.


ICG-14-thirdparty

As a company specialized in NGS, Nanodigmbio's total solution for the MGI platforms has been at the frontier of MGI's sequencing ecosystem. In addition to applications such as whole genome sequencing and exome sequencing, Nanodigmbio is the only vendor provides library construction and capture solutions for circulating tumor DNA. Nanodigmbio will continue to provide users with outstanding products and satisfactory services for customers from research institutions and industry organizations.

Back
Solutions
Events